全ゲノム増幅（WGA）の世界市場

全ゲノム増幅（WGA）の世界市場は2030年までに520万米ドルに達する見込み

2024年に360万米ドルと推定される全ゲノム増幅（WGA）の世界市場は、2024年から2030年にかけてCAGR 6.2%で成長し、2030年には520万米ドルに達すると予測されます。本レポートで分析したセグメントの1つであるシングルセルWGAキットは、CAGR 5.2％を記録し、分析期間終了までに160万米ドルに達すると予測されます。完全WGAキットセグメントの成長率は、分析期間中CAGR6.8％と推定されます。

米国市場は98万1,000米ドルと推定、中国はCAGR 9.5％で成長予測

米国の全ゲノム増幅（WGA）市場は、2024年に98万1,000米ドルと推定されます。世界第2位の経済大国である中国は、分析期間2024年から2030年にかけてCAGR 9.5%で推移し、2030年には予測市場規模100万米ドルに達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ3.1％と6.0％と予測されています。欧州では、ドイツがCAGR 4.0%で成長すると予測されています。

世界の全ゲノム増幅（WGA）市場- 主要動向と促進要因のまとめ

全ゲノム増幅はゲノム研究と分子診断をどう変えるか？

全ゲノム増幅（全ゲノム増幅（WGA））は、ゲノム科学における革新的な技術として登場し、研究者は最小限のサンプルや劣化したサンプルから大量のDNAを生成することができるようになりました。このプロセスは、着床前遺伝子診断、単一細胞分析、法医学、古代DNA研究など、サンプル量が本質的に限られている分野において特に重要です。WGAは、ゲノム全体の偏りのない増幅を可能にし、シーケンシング、ジェノタイピング、マイクロアレイ解析のような下流のアプリケーションのために遺伝的内容と構造を保持します。微量のDNAを扱う能力は、患者固有の遺伝情報を診断や治療の調整に用いる個別化医療において特に価値があります。WGAは、わずか1個の細胞から包括的なゲノムプロファイルを作成することを可能にし、がん生物学、希少疾患研究、生殖医療における新たなフロンティアを切り開きます。また、科学者が遺伝的多様性、突然変異パターン、種を超えた進化的関係をよりよく理解することも可能にしています。臨床の場では、WGAは遺伝子異常の早期発見をサポートします。感度、拡張性、多用途性の組み合わせにより、WGAは現代のゲノミクスの基礎的ツールとして位置づけられ、限られた生物学的サンプルと高解像度の遺伝的洞察に対する需要の高まりとのギャップを埋めています。

WGAの精度と効率を高める技術的進歩とは？

最近の技術革新は、全ゲノム増幅技術の性能、信頼性、利用しやすさを大幅に向上させています。ポリメラーゼ酵素、バッファーシステム、サーマルサイクリングプロトコルの改良により、エラー率やバイアスを減らし、より均一な増幅が可能になりつつあります。Multiple Displacement Amplification（MDA）のような等温増幅法は、ゲノムを高い忠実度で増幅し、配列の歪みを最小限に抑えることができるため、人気を博しています。マイクロ流体工学の革新もまた、細胞溶解と反応の組み立てに制御された環境を提供し、サンプルの損失と汚染を最小限に抑えることで、シングルセルWGAの効率を向上させています。自動化とハイスループット機能の統合により、ラボは数百から数千のサンプルを同時に処理できるようになり、これは大規模なゲノミクスプロジェクトや臨床診断に不可欠です。次世代シーケンシングプラットフォームはWGA製品との互換性が高まっており、この技術が使用できるアプリケーションの範囲をさらに拡大しています。増幅前後のDNA定量や完全性分析などの高度な品質管理手段により、高品質のサンプルのみが下流の分析に進むことが保証されています。このような技術開発により、増幅の結果が改善されるだけでなく、WGAはより再現性が高く、コスト効率に優れ、幅広いゲノムワークフローに適したものとなっています。精密医療とリアルタイムの遺伝子データへの需要が高まり続ける中、WGA技術は並行して進化し、DNA増幅のためのより合理的で正確なソリューションを提供することが期待されています。

業界を超えた多様なアプリケーションは、どのようにWGAの採用を促進しているのか？

ホールゲノムアンプリフィケーションの多用途性は、学術研究や臨床研究だけでなく、幅広い産業分野での採用を促進しています。生殖医療では、WGAは着床前遺伝学的検査において重要な役割を果たしており、臨床医が体外受精の際に着床前の胚に遺伝的障害がないかスクリーニングすることを可能にしています。腫瘍学では、個々のがん細胞からDNAを増幅することにより、腫瘍プロファイリングや腫瘍内不均一性の研究をサポートしています。これは、標的療法の開発や、循環腫瘍細胞や無細胞DNAサンプルの量が一般的に少ないリキッドバイオプシーにおいて、特に重要となっています。法医学者は、犯罪現場で発見された微量DNAの増幅にWGAを利用しており、高度に劣化したものや限られたものからでも身元確認が可能です。環境および微生物研究では、WGAは複雑な生態系における培養不可能な生物や希少な微生物群集のゲノム解析に使用されます。農業研究では、限られた組織サンプルを用いた植物遺伝学や耐病性形質の研究にWGAが役立っています。この方法は、少量のDNAサンプルを使って食事やフィットネスの推奨を調整する、個別化栄養学やウェルネス分野でも採用されています。規制環境が進化し、データ主導の意思決定が様々な分野で注目されるようになるにつれ、最小限のインプットから包括的な遺伝データを生成する能力の価値がますます高まっています。この広範な適用可能性が、既存市場と新興市場の両方でWGA技術に対する需要が高まっている強力な要因の一つです。

WGAソリューションの世界的拡大を牽引する市場力学とは？

世界の全ゲノム増幅市場は、科学的、技術的、商業的要因の収束により急速に拡大しており、遺伝子研究と診断の状況を再構築しています。公的機関と民間のバイオテクノロジー企業の両方によるゲノム研究への投資の増加は、困難なサンプルに対応できる信頼性の高い増幅技術へのニーズに拍車をかけています。リキッドバイオプシーやシングルセル解析で使用されるようなサンプリング技術の継続的な小型化により、データの質を損なうことなく少量の遺伝物質を増幅できるWGAソリューションに対する需要が高まっています。個別化医療や精密診断へのシフトも、臨床医や研究者が個別の治療計画を導くための包括的なゲノムデータを求めていることから、WGAへの関心を高めています。学術機関、診断ラボ、テクノロジープロバイダー間の提携により、特定の用途やワークフローに合わせた新しいWGAキットの開発と検証が加速しています。高品質のDNAインプットに依存する次世代シーケンシング技術の利用可能性が高まっており、臨床および研究パイプラインにおけるWGAの関連性がさらに高まっています。多くの国々で遺伝子検査と早期疾患スクリーニングに対する規制支援が遺伝子ツールの幅広い採用を促し、市場浸透の新たな機会を生み出しています。さらに、消費者ゲノミクスと消費者直接遺伝子検査の台頭は、容易に拡大・標準化できるサンプルに優しい増幅法に対する需要を高めています。これらのダイナミクスが相まって、WGAは世界のゲノミクスエコシステムの重要かつ急速に進化する要素であり続けています。

セグメント

タイプ（シングルセルWGAキット、完全WGAキット、WGA再増幅キット、WGA &チップDNAキット、その他のタイプ）、用途（創薬・開発、診断、研究、法医学、その他の用途）、エンドユーザー（製薬・バイオテクノロジー企業病院・クリニック研究機関、その他のエンドユーザー）

調査対象企業の例

• BGI Group/MGI Tech
• AgilentTechnologies
• Applied Biosystems（Thermo Fisher）
• BioSkryb Genomics
• Complete Genomics
• Fluidigm（Standard BioTools）
• Illumina, Inc.
• LGC Biosearch Technologies
• Merck（Sigma-Aldrich）
• MGI Tech
• NanoString Technologies
• New England Biolabs
• Oxford Nanopore Technologies
• PacBio（Pacific Biosciences）
• Paragon Genomics
• Promega Corporation
• QIAGEN NV
• Roche
• ScienCell Analytics
• Thermo Fisher Scientific

AIインテグレーション

Global Industry Analystsは、有効な専門家コンテンツとAIツールにより、市場情報と競合情報を変革しています。

Global Industry Analystsは、一般的なLLMや業界別SLMのクエリに従う代わりに、ビデオ記録、ブログ、検索エンジン調査、大量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

• 市場概要
• 主要企業
• 市場動向と促進要因
• 世界市場の見通し

第3章 市場分析

• 米国
• カナダ
• 日本
• 中国
• 欧州
• フランス
• ドイツ
• イタリア
• 英国
• スペイン
• ロシア
• その他欧州
• アジア太平洋
• オーストラリア
• インド
• 韓国
• その他アジア太平洋地域
• ラテンアメリカ
• アルゼンチン
• ブラジル
• メキシコ
• その他ラテンアメリカ
• 中東
• イラン
• イスラエル
• サウジアラビア
• アラブ首長国連邦
• その他中東
• アフリカ

第4章 競合

Global Whole Genome Amplification (WGA) Market to Reach US$5.2 Million by 2030

The global market for Whole Genome Amplification (WGA) estimated at US$3.6 Million in the year 2024, is expected to reach US$5.2 Million by 2030, growing at a CAGR of 6.2% over the analysis period 2024-2030. Single Cell WGA Kit, one of the segments analyzed in the report, is expected to record a 5.2% CAGR and reach US$1.6 Million by the end of the analysis period. Growth in the Complete WGA Kit segment is estimated at 6.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$981.0 Thousand While China is Forecast to Grow at 9.5% CAGR

The Whole Genome Amplification (WGA) market in the U.S. is estimated at US$981.0 Thousand in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$1.0 Million by the year 2030 trailing a CAGR of 9.5% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.1% and 6.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.0% CAGR.

Global Whole Genome Amplification (WGA) Market - Key Trends & Drivers Summarized

How Is Whole Genome Amplification Transforming Genomic Research and Molecular Diagnostics?

Whole Genome Amplification (WGA) has emerged as a transformative technique in genomic science, enabling researchers to generate large quantities of DNA from minimal or degraded samples. This process is particularly critical in fields where sample quantity is inherently limited, such as preimplantation genetic diagnosis, single-cell analysis, forensic science, and ancient DNA studies. WGA allows for the unbiased amplification of the entire genome, preserving the genetic content and structure for downstream applications like sequencing, genotyping, and microarray analysis. The ability to work with minute DNA quantities is especially valuable in personalized medicine, where patient-specific genetic information is used to tailor diagnostics and treatments. WGA ensures that a comprehensive genomic profile can be developed from as little as a single cell, opening new frontiers in cancer biology, rare disease research, and reproductive health. It is also enabling scientists to better understand genetic diversity, mutation patterns, and evolutionary relationships across species. In clinical settings, WGA supports the early detection of genetic abnormalities, often before traditional methods are feasible. The combination of sensitivity, scalability, and versatility is positioning WGA as a foundational tool in modern genomics, bridging the gap between limited biological samples and the growing demand for high-resolution genetic insights.

What Technological Advancements Are Enhancing the Precision and Efficiency of WGA?

Recent technological innovations are significantly enhancing the performance, reliability, and accessibility of Whole Genome Amplification techniques. Improvements in polymerase enzymes, buffer systems, and thermal cycling protocols are enabling more uniform amplification with reduced error rates and bias. Isothermal amplification methods such as Multiple Displacement Amplification (MDA) have gained traction due to their ability to amplify genomes with high fidelity and minimal sequence distortion. Innovations in microfluidics are also improving the efficiency of single-cell WGA by providing controlled environments for cell lysis and reaction assembly, minimizing sample loss and contamination. The integration of automation and high-throughput capabilities is allowing laboratories to process hundreds or even thousands of samples simultaneously, which is crucial for large-scale genomics projects and clinical diagnostics. Next-generation sequencing platforms are increasingly compatible with WGA products, further expanding the range of applications in which this technique can be used. Advanced quality control measures, such as pre- and post-amplification DNA quantification and integrity analysis, are ensuring that only high-quality samples proceed to downstream analysis. These technological developments are not only improving amplification outcomes but also making WGA more reproducible, cost-effective, and suitable for a wider array of genomic workflows. As the demand for precision medicine and real-time genetic data continues to grow, WGA technologies are expected to evolve in parallel, offering more streamlined and accurate solutions for DNA amplification.

How Are Diverse Applications Across Industries Fueling the Adoption of WGA?

The versatility of Whole Genome Amplification is driving its adoption across a broad spectrum of industries beyond just academic and clinical research. In reproductive health, WGA is playing a crucial role in preimplantation genetic testing, allowing clinicians to screen embryos for genetic disorders before implantation during in vitro fertilization procedures. In oncology, the technique supports tumor profiling and the study of intratumoral heterogeneity by amplifying DNA from individual cancer cells. This has become especially relevant in the development of targeted therapies and liquid biopsies, where circulating tumor cells and cell-free DNA samples are typically low in quantity. Forensic scientists rely on WGA to amplify trace DNA found at crime scenes, enabling identity verification even from highly degraded or limited material. In environmental and microbial studies, WGA is used to analyze the genomes of unculturable organisms or rare microbial communities in complex ecosystems. Agricultural research benefits from WGA in studying plant genetics and disease resistance traits using limited tissue samples. The method is also being adopted in personalized nutrition and wellness sectors, where small DNA samples are used to tailor diet and fitness recommendations. As regulatory environments evolve and data-driven decision-making gains prominence in diverse sectors, the ability to generate comprehensive genetic data from minimal inputs is becoming increasingly valuable. This widespread applicability is one of the strongest forces behind the rising demand for WGA technologies across both established and emerging markets.

What Market Dynamics Are Driving the Global Expansion of WGA Solutions?

The global Whole Genome Amplification market is expanding rapidly due to a convergence of scientific, technological, and commercial factors that are reshaping the landscape of genetic research and diagnostics. Increasing investment in genomics research by both public institutions and private biotechnology firms is fueling the need for reliable amplification technologies capable of handling challenging samples. The continued miniaturization of sampling techniques, such as those used in liquid biopsy and single-cell analysis, is creating a growing demand for WGA solutions that can amplify small amounts of genetic material without compromising data quality. The shift toward personalized medicine and precision diagnostics is also amplifying interest in WGA as clinicians and researchers seek comprehensive genomic data to guide individualized treatment plans. Partnerships between academic institutions, diagnostic laboratories, and technology providers are accelerating the development and validation of new WGA kits tailored for specific applications and workflows. The growing availability of next-generation sequencing technologies, which rely on high-quality DNA input, is further boosting the relevance of WGA in clinical and research pipelines. Regulatory support for genetic testing and early disease screening in many countries is encouraging broader adoption of genetic tools, creating new opportunities for market penetration. Additionally, the rise of consumer genomics and direct-to-consumer genetic testing is increasing demand for sample-friendly amplification methods that can be easily scaled and standardized. Together, these dynamics are ensuring that WGA remains a critical and rapidly evolving component of the global genomics ecosystem.

SCOPE OF STUDY:

The report analyzes the Whole Genome Amplification (WGA) market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Single Cell WGA Kit, Complete WGA Kit, WGA Reamplification Kit, WGA & Chip DNA Kit, Other Types); Application (Drug Discovery & Development Application, Diagnostics Application, Research Application, Forensics Application, Other Applications); End-User (Pharma & Biotech Companies End-User, Hospitals & Clinics End-User, Research Institutes End-User, Other End-Users)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 48 Featured) -

• BGI Group / MGI Tech
• AgilentTechnologies
• Applied Biosystems (Thermo Fisher)
• BioSkryb Genomics
• Complete Genomics
• Fluidigm (Standard BioTools)
• Illumina, Inc.
• LGC Biosearch Technologies
• Merck (Sigma-Aldrich)
• MGI Tech
• NanoString Technologies
• New England Biolabs
• Oxford Nanopore Technologies
• PacBio (Pacific Biosciences)
• Paragon Genomics
• Promega Corporation
• QIAGEN NV
• Roche
• ScienCell Analytics
• Thermo Fisher Scientific

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Tariff Impact on Global Supply Chain Patterns
  • Whole Genome Amplification (WGA) - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Demand for Single-Cell Genomics Throws the Spotlight on High-Fidelity WGA Techniques
  • Expansion of Personalized Medicine and Genomic Research Spurs Growth in WGA Applications
  • Advancements in Next-Generation Sequencing Expand Addressable Market for Pre-Amplification Solutions
  • Increasing Use of Liquid Biopsies and Rare Cell Analysis Strengthens the Business Case for Sensitive WGA Kits
  • Growth in Non-Invasive Prenatal Testing (NIPT) Drives Adoption of Low-Input DNA Amplification Technologies
  • Forensic and Ancient DNA Analysis Needs Propel Innovation in Ultra-Low Input WGA Solutions
  • Microbiome and Metagenomic Studies Highlight the Role of Bias-Minimized WGA Protocols
  • Synthetic Biology and Gene Editing Applications Generate Opportunities for High-Precision Amplification Tools
  • Global Focus on Infectious Disease Surveillance Sustains Growth in Pathogen Genomic Amplification
  • Automation and Workflow Integration Drive Adoption of WGA in Clinical and Lab Automation Systems
  • Research in Isothermal and PCR-Free Amplification Technologies Fuel Competitive Innovation
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Whole Genome Amplification (WGA) Market Analysis of Annual Sales in US$ for Years 2014 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Whole Genome Amplification (WGA) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Whole Genome Amplification (WGA) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 4: World 16-Year Perspective for Whole Genome Amplification (WGA) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Single Cell WGA Kit by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Single Cell WGA Kit by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 7: World 16-Year Perspective for Single Cell WGA Kit by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Complete WGA Kit by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Complete WGA Kit by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 10: World 16-Year Perspective for Complete WGA Kit by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for WGA Reamplification Kit by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for WGA Reamplification Kit by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 13: World 16-Year Perspective for WGA Reamplification Kit by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for WGA & Chip DNA Kit by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for WGA & Chip DNA Kit by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 16: World 16-Year Perspective for WGA & Chip DNA Kit by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 19: World 16-Year Perspective for Other Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 22: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Drug Discovery & Development Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Drug Discovery & Development Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 25: World 16-Year Perspective for Drug Discovery & Development Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Diagnostics Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Diagnostics Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 28: World 16-Year Perspective for Diagnostics Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Research Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Research Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 31: World 16-Year Perspective for Research Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Forensics Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for Forensics Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 34: World 16-Year Perspective for Forensics Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 35: World Recent Past, Current & Future Analysis for Pharma & Biotech Companies End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 36: World Historic Review for Pharma & Biotech Companies End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 37: World 16-Year Perspective for Pharma & Biotech Companies End-User by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 38: World Recent Past, Current & Future Analysis for Hospitals & Clinics End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 39: World Historic Review for Hospitals & Clinics End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 40: World 16-Year Perspective for Hospitals & Clinics End-User by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 41: World Recent Past, Current & Future Analysis for Research Institutes End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 42: World Historic Review for Research Institutes End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 43: World 16-Year Perspective for Research Institutes End-User by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 44: World Recent Past, Current & Future Analysis for Other End-Users by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 45: World Historic Review for Other End-Users by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 46: World 16-Year Perspective for Other End-Users by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Whole Genome Amplification (WGA) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 47: USA Recent Past, Current & Future Analysis for Whole Genome Amplification (WGA) by Type - Single Cell WGA Kit, Complete WGA Kit, WGA Reamplification Kit, WGA & Chip DNA Kit and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 48: USA Historic Review for Whole Genome Amplification (WGA) by Type - Single Cell WGA Kit, Complete WGA Kit, WGA Reamplification Kit, WGA & Chip DNA Kit and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 49: USA 16-Year Perspective for Whole Genome Amplification (WGA) by Type - Percentage Breakdown of Value Sales for Single Cell WGA Kit, Complete WGA Kit, WGA Reamplification Kit, WGA & Chip DNA Kit and Other Types for the Years 2014, 2025 & 2030
  • TABLE 50: USA Recent Past, Current & Future Analysis for Whole Genome Amplification (WGA) by Application - Other Applications, Drug Discovery & Development Application, Diagnostics Application, Research Application and Forensics Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 51: USA Historic Review for Whole Genome Amplification (WGA) by Application - Other Applications, Drug Discovery & Development Application, Diagnostics Application, Research Application and Forensics Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 52: USA 16-Year Perspective for Whole Genome Amplification (WGA) by Application - Percentage Breakdown of Value Sales for Other Applications, Drug Discovery & Development Application, Diagnostics Application, Research Application and Forensics Application for the Years 2014, 2025 & 2030
  • TABLE 53: USA Recent Past, Current & Future Analysis for Whole Genome Amplification (WGA) by End-user - Pharma & Biotech Companies End-User, Hospitals & Clinics End-User, Research Institutes End-User and Other End-Users - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 54: USA Historic Review for Whole Genome Amplification (WGA) by End-user - Pharma & Biotech Companies End-User, Hospitals & Clinics End-User, Research Institutes End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 55: USA 16-Year Perspective for Whole Genome Amplification (WGA) by End-user - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-User, Hospitals & Clinics End-User, Research Institutes End-User and Other End-Users for the Years 2014, 2025 & 2030
• CANADA
  • TABLE 56: Canada Recent Past, Current & Future Analysis for Whole Genome Amplification (WGA) by Type - Single Cell WGA Kit, Complete WGA Kit, WGA Reamplification Kit, WGA & Chip DNA Kit and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 57: Canada Historic Review for Whole Genome Amplification (WGA) by Type - Single Cell WGA Kit, Complete WGA Kit, WGA Reamplification Kit, WGA & Chip DNA Kit and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 58: Canada 16-Year Perspective for Whole Genome Amplification (WGA) by Type - Percentage Breakdown of Value Sales for Single Cell WGA Kit, Complete WGA Kit, WGA Reamplification Kit, WGA & Chip DNA Kit and Other Types for the Years 2014, 2025 & 2030
  • TABLE 59: Canada Recent Past, Current & Future Analysis for Whole Genome Amplification (WGA) by Application - Other Applications, Drug Discovery & Development Application, Diagnostics Application, Research Application and Forensics Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 60: Canada Historic Review for Whole Genome Amplification (WGA) by Application - Other Applications, Drug Discovery & Development Application, Diagnostics Application, Research Application and Forensics Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 61: Canada 16-Year Perspective for Whole Genome Amplification (WGA) by Application - Percentage Breakdown of Value Sales for Other Applications, Drug Discovery & Development Application, Diagnostics Application, Research Application and Forensics Application for the Years 2014, 2025 & 2030
  • TABLE 62: Canada Recent Past, Current & Future Analysis for Whole Genome Amplification (WGA) by End-user - Pharma & Biotech Companies End-User, Hospitals & Clinics End-User, Research Institutes End-User and Other End-Users - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 63: Canada Historic Review for Whole Genome Amplification (WGA) by End-user - Pharma & Biotech Companies End-User, Hospitals & Clinics End-User, Research Institutes End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 64: Canada 16-Year Perspective for Whole Genome Amplification (WGA) by End-user - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-User, Hospitals & Clinics End-User, Research Institutes End-User and Other End-Users for the Years 2014, 2025 & 2030
• JAPAN
  • Whole Genome Amplification (WGA) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 65: Japan Recent Past, Current & Future Analysis for Whole Genome Amplification (WGA) by Type - Single Cell WGA Kit, Complete WGA Kit, WGA Reamplification Kit, WGA & Chip DNA Kit and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 66: Japan Historic Review for Whole Genome Amplification (WGA) by Type - Single Cell WGA Kit, Complete WGA Kit, WGA Reamplification Kit, WGA & Chip DNA Kit and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 67: Japan 16-Year Perspective for Whole Genome Amplification (WGA) by Type - Percentage Breakdown of Value Sales for Single Cell WGA Kit, Complete WGA Kit, WGA Reamplification Kit, WGA & Chip DNA Kit and Other Types for the Years 2014, 2025 & 2030
  • TABLE 68: Japan Recent Past, Current & Future Analysis for Whole Genome Amplification (WGA) by Application - Other Applications, Drug Discovery & Development Application, Diagnostics Application, Research Application and Forensics Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 69: Japan Historic Review for Whole Genome Amplification (WGA) by Application - Other Applications, Drug Discovery & Development Application, Diagnostics Application, Research Application and Forensics Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 70: Japan 16-Year Perspective for Whole Genome Amplification (WGA) by Application - Percentage Breakdown of Value Sales for Other Applications, Drug Discovery & Development Application, Diagnostics Application, Research Application and Forensics Application for the Years 2014, 2025 & 2030
  • TABLE 71: Japan Recent Past, Current & Future Analysis for Whole Genome Amplification (WGA) by End-user - Pharma & Biotech Companies End-User, Hospitals & Clinics End-User, Research Institutes End-User and Other End-Users - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 72: Japan Historic Review for Whole Genome Amplification (WGA) by End-user - Pharma & Biotech Companies End-User, Hospitals & Clinics End-User, Research Institutes End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 73: Japan 16-Year Perspective for Whole Genome Amplification (WGA) by End-user - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-User, Hospitals & Clinics End-User, Research Institutes End-User and Other End-Users for the Years 2014, 2025 & 2030
• CHINA
  • Whole Genome Amplification (WGA) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 74: China Recent Past, Current & Future Analysis for Whole Genome Amplification (WGA) by Type - Single Cell WGA Kit, Complete WGA Kit, WGA Reamplification Kit, WGA & Chip DNA Kit and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 75: China Historic Review for Whole Genome Amplification (WGA) by Type - Single Cell WGA Kit, Complete WGA Kit, WGA Reamplification Kit, WGA & Chip DNA Kit and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 76: China 16-Year Perspective for Whole Genome Amplification (WGA) by Type - Percentage Breakdown of Value Sales for Single Cell WGA Kit, Complete WGA Kit, WGA Reamplification Kit, WGA & Chip DNA Kit and Other Types for the Years 2014, 2025 & 2030
  • TABLE 77: China Recent Past, Current & Future Analysis for Whole Genome Amplification (WGA) by Application - Other Applications, Drug Discovery & Development Application, Diagnostics Application, Research Application and Forensics Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 78: China Historic Review for Whole Genome Amplification (WGA) by Application - Other Applications, Drug Discovery & Development Application, Diagnostics Application, Research Application and Forensics Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 79: China 16-Year Perspective for Whole Genome Amplification (WGA) by Application - Percentage Breakdown of Value Sales for Other Applications, Drug Discovery & Development Application, Diagnostics Application, Research Application and Forensics Application for the Years 2014, 2025 & 2030
  • TABLE 80: China Recent Past, Current & Future Analysis for Whole Genome Amplification (WGA) by End-user - Pharma & Biotech Companies End-User, Hospitals & Clinics End-User, Research Institutes End-User and Other End-Users - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 81: China Historic Review for Whole Genome Amplification (WGA) by End-user - Pharma & Biotech Companies End-User, Hospitals & Clinics End-User, Research Institutes End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 82: China 16-Year Perspective for Whole Genome Amplification (WGA) by End-user - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-User, Hospitals & Clinics End-User, Research Institutes End-User and Other End-Users for the Years 2014, 2025 & 2030
• EUROPE
  • Whole Genome Amplification (WGA) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 83: Europe Recent Past, Current & Future Analysis for Whole Genome Amplification (WGA) by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 84: Europe Historic Review for Whole Genome Amplification (WGA) by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 85: Europe 16-Year Perspective for Whole Genome Amplification (WGA) by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
  • TABLE 86: Europe Recent Past, Current & Future Analysis for Whole Genome Amplification (WGA) by Type - Single Cell WGA Kit, Complete WGA Kit, WGA Reamplification Kit, WGA & Chip DNA Kit and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 87: Europe Historic Review for Whole Genome Amplification (WGA) by Type - Single Cell WGA Kit, Complete WGA Kit, WGA Reamplification Kit, WGA & Chip DNA Kit and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 88: Europe 16-Year Perspective for Whole Genome Amplification (WGA) by Type - Percentage Breakdown of Value Sales for Single Cell WGA Kit, Complete WGA Kit, WGA Reamplification Kit, WGA & Chip DNA Kit and Other Types for the Years 2014, 2025 & 2030
  • TABLE 89: Europe Recent Past, Current & Future Analysis for Whole Genome Amplification (WGA) by Application - Other Applications, Drug Discovery & Development Application, Diagnostics Application, Research Application and Forensics Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 90: Europe Historic Review for Whole Genome Amplification (WGA) by Application - Other Applications, Drug Discovery & Development Application, Diagnostics Application, Research Application and Forensics Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 91: Europe 16-Year Perspective for Whole Genome Amplification (WGA) by Application - Percentage Breakdown of Value Sales for Other Applications, Drug Discovery & Development Application, Diagnostics Application, Research Application and Forensics Application for the Years 2014, 2025 & 2030
  • TABLE 92: Europe Recent Past, Current & Future Analysis for Whole Genome Amplification (WGA) by End-user - Pharma & Biotech Companies End-User, Hospitals & Clinics End-User, Research Institutes End-User and Other End-Users - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 93: Europe Historic Review for Whole Genome Amplification (WGA) by End-user - Pharma & Biotech Companies End-User, Hospitals & Clinics End-User, Research Institutes End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 94: Europe 16-Year Perspective for Whole Genome Amplification (WGA) by End-user - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-User, Hospitals & Clinics End-User, Research Institutes End-User and Other End-Users for the Years 2014, 2025 & 2030
• FRANCE
  • Whole Genome Amplification (WGA) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 95: France Recent Past, Current & Future Analysis for Whole Genome Amplification (WGA) by Type - Single Cell WGA Kit, Complete WGA Kit, WGA Reamplification Kit, WGA & Chip DNA Kit and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 96: France Historic Review for Whole Genome Amplification (WGA) by Type - Single Cell WGA Kit, Complete WGA Kit, WGA Reamplification Kit, WGA & Chip DNA Kit and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 97: France 16-Year Perspective for Whole Genome Amplification (WGA) by Type - Percentage Breakdown of Value Sales for Single Cell WGA Kit, Complete WGA Kit, WGA Reamplification Kit, WGA & Chip DNA Kit and Other Types for the Years 2014, 2025 & 2030
  • TABLE 98: France Recent Past, Current & Future Analysis for Whole Genome Amplification (WGA) by Application - Other Applications, Drug Discovery & Development Application, Diagnostics Application, Research Application and Forensics Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 99: France Historic Review for Whole Genome Amplification (WGA) by Application - Other Applications, Drug Discovery & Development Application, Diagnostics Application, Research Application and Forensics Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 100: France 16-Year Perspective for Whole Genome Amplification (WGA) by Application - Percentage Breakdown of Value Sales for Other Applications, Drug Discovery & Development Application, Diagnostics Application, Research Application and Forensics Application for the Years 2014, 2025 & 2030
  • TABLE 101: France Recent Past, Current & Future Analysis for Whole Genome Amplification (WGA) by End-user - Pharma & Biotech Companies End-User, Hospitals & Clinics End-User, Research Institutes End-User and Other End-Users - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 102: France Historic Review for Whole Genome Amplification (WGA) by End-user - Pharma & Biotech Companies End-User, Hospitals & Clinics End-User, Research Institutes End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 103: France 16-Year Perspective for Whole Genome Amplification (WGA) by End-user - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-User, Hospitals & Clinics End-User, Research Institutes End-User and Other End-Users for the Years 2014, 2025 & 2030
• GERMANY
  • Whole Genome Amplification (WGA) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 104: Germany Recent Past, Current & Future Analysis for Whole Genome Amplification (WGA) by Type - Single Cell WGA Kit, Complete WGA Kit, WGA Reamplification Kit, WGA & Chip DNA Kit and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 105: Germany Historic Review for Whole Genome Amplification (WGA) by Type - Single Cell WGA Kit, Complete WGA Kit, WGA Reamplification Kit, WGA & Chip DNA Kit and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 106: Germany 16-Year Perspective for Whole Genome Amplification (WGA) by Type - Percentage Breakdown of Value Sales for Single Cell WGA Kit, Complete WGA Kit, WGA Reamplification Kit, WGA & Chip DNA Kit and Other Types for the Years 2014, 2025 & 2030
  • TABLE 107: Germany Recent Past, Current & Future Analysis for Whole Genome Amplification (WGA) by Application - Other Applications, Drug Discovery & Development Application, Diagnostics Application, Research Application and Forensics Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 108: Germany Historic Review for Whole Genome Amplification (WGA) by Application - Other Applications, Drug Discovery & Development Application, Diagnostics Application, Research Application and Forensics Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 109: Germany 16-Year Perspective for Whole Genome Amplification (WGA) by Application - Percentage Breakdown of Value Sales for Other Applications, Drug Discovery & Development Application, Diagnostics Application, Research Application and Forensics Application for the Years 2014, 2025 & 2030
  • TABLE 110: Germany Recent Past, Current & Future Analysis for Whole Genome Amplification (WGA) by End-user - Pharma & Biotech Companies End-User, Hospitals & Clinics End-User, Research Institutes End-User and Other End-Users - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 111: Germany Historic Review for Whole Genome Amplification (WGA) by End-user - Pharma & Biotech Companies End-User, Hospitals & Clinics End-User, Research Institutes End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 112: Germany 16-Year Perspective for Whole Genome Amplification (WGA) by End-user - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-User, Hospitals & Clinics End-User, Research Institutes End-User and Other End-Users for the Years 2014, 2025 & 2030
• ITALY
  • TABLE 113: Italy Recent Past, Current & Future Analysis for Whole Genome Amplification (WGA) by Type - Single Cell WGA Kit, Complete WGA Kit, WGA Reamplification Kit, WGA & Chip DNA Kit and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 114: Italy Historic Review for Whole Genome Amplification (WGA) by Type - Single Cell WGA Kit, Complete WGA Kit, WGA Reamplification Kit, WGA & Chip DNA Kit and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 115: Italy 16-Year Perspective for Whole Genome Amplification (WGA) by Type - Percentage Breakdown of Value Sales for Single Cell WGA Kit, Complete WGA Kit, WGA Reamplification Kit, WGA & Chip DNA Kit and Other Types for the Years 2014, 2025 & 2030
  • TABLE 116: Italy Recent Past, Current & Future Analysis for Whole Genome Amplification (WGA) by Application - Other Applications, Drug Discovery & Development Application, Diagnostics Application, Research Application and Forensics Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 117: Italy Historic Review for Whole Genome Amplification (WGA) by Application - Other Applications, Drug Discovery & Development Application, Diagnostics Application, Research Application and Forensics Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 118: Italy 16-Year Perspective for Whole Genome Amplification (WGA) by Application - Percentage Breakdown of Value Sales for Other Applications, Drug Discovery & Development Application, Diagnostics Application, Research Application and Forensics Application for the Years 2014, 2025 & 2030
  • TABLE 119: Italy Recent Past, Current & Future Analysis for Whole Genome Amplification (WGA) by End-user - Pharma & Biotech Companies End-User, Hospitals & Clinics End-User, Research Institutes End-User and Other End-Users - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 120: Italy Historic Review for Whole Genome Amplification (WGA) by End-user - Pharma & Biotech Companies End-User, Hospitals & Clinics End-User, Research Institutes End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 121: Italy 16-Year Perspective for Whole Genome Amplification (WGA) by End-user - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-User, Hospitals & Clinics End-User, Research Institutes End-User and Other End-Users for the Years 2014, 2025 & 2030
• UNITED KINGDOM
  • Whole Genome Amplification (WGA) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 122: UK Recent Past, Current & Future Analysis for Whole Genome Amplification (WGA) by Type - Single Cell WGA Kit, Complete WGA Kit, WGA Reamplification Kit, WGA & Chip DNA Kit and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 123: UK Historic Review for Whole Genome Amplification (WGA) by Type - Single Cell WGA Kit, Complete WGA Kit, WGA Reamplification Kit, WGA & Chip DNA Kit and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 124: UK 16-Year Perspective for Whole Genome Amplification (WGA) by Type - Percentage Breakdown of Value Sales for Single Cell WGA Kit, Complete WGA Kit, WGA Reamplification Kit, WGA & Chip DNA Kit and Other Types for the Years 2014, 2025 & 2030
  • TABLE 125: UK Recent Past, Current & Future Analysis for Whole Genome Amplification (WGA) by Application - Other Applications, Drug Discovery & Development Application, Diagnostics Application, Research Application and Forensics Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 126: UK Historic Review for Whole Genome Amplification (WGA) by Application - Other Applications, Drug Discovery & Development Application, Diagnostics Application, Research Application and Forensics Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 127: UK 16-Year Perspective for Whole Genome Amplification (WGA) by Application - Percentage Breakdown of Value Sales for Other Applications, Drug Discovery & Development Application, Diagnostics Application, Research Application and Forensics Application for the Years 2014, 2025 & 2030
  • TABLE 128: UK Recent Past, Current & Future Analysis for Whole Genome Amplification (WGA) by End-user - Pharma & Biotech Companies End-User, Hospitals & Clinics End-User, Research Institutes End-User and Other End-Users - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 129: UK Historic Review for Whole Genome Amplification (WGA) by End-user - Pharma & Biotech Companies End-User, Hospitals & Clinics End-User, Research Institutes End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 130: UK 16-Year Perspective for Whole Genome Amplification (WGA) by End-user - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-User, Hospitals & Clinics End-User, Research Institutes End-User and Other End-Users for the Years 2014, 2025 & 2030
• SPAIN
  • TABLE 131: Spain Recent Past, Current & Future Analysis for Whole Genome Amplification (WGA) by Type - Single Cell WGA Kit, Complete WGA Kit, WGA Reamplification Kit, WGA & Chip DNA Kit and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Spain Historic Review for Whole Genome Amplification (WGA) by Type - Single Cell WGA Kit, Complete WGA Kit, WGA Reamplification Kit, WGA & Chip DNA Kit and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 133: Spain 16-Year Perspective for Whole Genome Amplification (WGA) by Type - Percentage Breakdown of Value Sales for Single Cell WGA Kit, Complete WGA Kit, WGA Reamplification Kit, WGA & Chip DNA Kit and Other Types for the Years 2014, 2025 & 2030
  • TABLE 134: Spain Recent Past, Current & Future Analysis for Whole Genome Amplification (WGA) by Application - Other Applications, Drug Discovery & Development Application, Diagnostics Application, Research Application and Forensics Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Spain Historic Review for Whole Genome Amplification (WGA) by Application - Other Applications, Drug Discovery & Development Application, Diagnostics Application, Research Application and Forensics Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 136: Spain 16-Year Perspective for Whole Genome Amplification (WGA) by Application - Percentage Breakdown of Value Sales for Other Applications, Drug Discovery & Development Application, Diagnostics Application, Research Application and Forensics Application for the Years 2014, 2025 & 2030
  • TABLE 137: Spain Recent Past, Current & Future Analysis for Whole Genome Amplification (WGA) by End-user - Pharma & Biotech Companies End-User, Hospitals & Clinics End-User, Research Institutes End-User and Other End-Users - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Spain Historic Review for Whole Genome Amplification (WGA) by End-user - Pharma & Biotech Companies End-User, Hospitals & Clinics End-User, Research Institutes End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 139: Spain 16-Year Perspective for Whole Genome Amplification (WGA) by End-user - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-User, Hospitals & Clinics End-User, Research Institutes End-User and Other End-Users for the Years 2014, 2025 & 2030
• RUSSIA
  • TABLE 140: Russia Recent Past, Current & Future Analysis for Whole Genome Amplification (WGA) by Type - Single Cell WGA Kit, Complete WGA Kit, WGA Reamplification Kit, WGA & Chip DNA Kit and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Russia Historic Review for Whole Genome Amplification (WGA) by Type - Single Cell WGA Kit, Complete WGA Kit, WGA Reamplification Kit, WGA & Chip DNA Kit and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 142: Russia 16-Year Perspective for Whole Genome Amplification (WGA) by Type - Percentage Breakdown of Value Sales for Single Cell WGA Kit, Complete WGA Kit, WGA Reamplification Kit, WGA & Chip DNA Kit and Other Types for the Years 2014, 2025 & 2030
  • TABLE 143: Russia Recent Past, Current & Future Analysis for Whole Genome Amplification (WGA) by Application - Other Applications, Drug Discovery & Development Application, Diagnostics Application, Research Application and Forensics Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 144: Russia Historic Review for Whole Genome Amplification (WGA) by Application - Other Applications, Drug Discovery & Development Application, Diagnostics Application, Research Application and Forensics Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 145: Russia 16-Year Perspective for Whole Genome Amplification (WGA) by Application - Percentage Breakdown of Value Sales for Other Applications, Drug Discovery & Development Application, Diagnostics Application, Research Application and Forensics Application for the Years 2014, 2025 & 2030
  • TABLE 146: Russia Recent Past, Current & Future Analysis for Whole Genome Amplification (WGA) by End-user - Pharma & Biotech Companies End-User, Hospitals & Clinics End-User, Research Institutes End-User and Other End-Users - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 147: Russia Historic Review for Whole Genome Amplification (WGA) by End-user - Pharma & Biotech Companies End-User, Hospitals & Clinics End-User, Research Institutes End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 148: Russia 16-Year Perspective for Whole Genome Amplification (WGA) by End-user - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-User, Hospitals & Clinics End-User, Research Institutes End-User and Other End-Users for the Years 2014, 2025 & 2030
• REST OF EUROPE
  • TABLE 149: Rest of Europe Recent Past, Current & Future Analysis for Whole Genome Amplification (WGA) by Type - Single Cell WGA Kit, Complete WGA Kit, WGA Reamplification Kit, WGA & Chip DNA Kit and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 150: Rest of Europe Historic Review for Whole Genome Amplification (WGA) by Type - Single Cell WGA Kit, Complete WGA Kit, WGA Reamplification Kit, WGA & Chip DNA Kit and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 151: Rest of Europe 16-Year Perspective for Whole Genome Amplification (WGA) by Type - Percentage Breakdown of Value Sales for Single Cell WGA Kit, Complete WGA Kit, WGA Reamplification Kit, WGA & Chip DNA Kit and Other Types for the Years 2014, 2025 & 2030
  • TABLE 152: Rest of Europe Recent Past, Current & Future Analysis for Whole Genome Amplification (WGA) by Application - Other Applications, Drug Discovery & Development Application, Diagnostics Application, Research Application and Forensics Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 153: Rest of Europe Historic Review for Whole Genome Amplification (WGA) by Application - Other Applications, Drug Discovery & Development Application, Diagnostics Application, Research Application and Forensics Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 154: Rest of Europe 16-Year Perspective for Whole Genome Amplification (WGA) by Application - Percentage Breakdown of Value Sales for Other Applications, Drug Discovery & Development Application, Diagnostics Application, Research Application and Forensics Application for the Years 2014, 2025 & 2030
  • TABLE 155: Rest of Europe Recent Past, Current & Future Analysis for Whole Genome Amplification (WGA) by End-user - Pharma & Biotech Companies End-User, Hospitals & Clinics End-User, Research Institutes End-User and Other End-Users - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Rest of Europe Historic Review for Whole Genome Amplification (WGA) by End-user - Pharma & Biotech Companies End-User, Hospitals & Clinics End-User, Research Institutes End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 157: Rest of Europe 16-Year Perspective for Whole Genome Amplification (WGA) by End-user - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-User, Hospitals & Clinics End-User, Research Institutes End-User and Other End-Users for the Years 2014, 2025 & 2030
• ASIA-PACIFIC
  • Whole Genome Amplification (WGA) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 158: Asia-Pacific Recent Past, Current & Future Analysis for Whole Genome Amplification (WGA) by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 159: Asia-Pacific Historic Review for Whole Genome Amplification (WGA) by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 160: Asia-Pacific 16-Year Perspective for Whole Genome Amplification (WGA) by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
  • TABLE 161: Asia-Pacific Recent Past, Current & Future Analysis for Whole Genome Amplification (WGA) by Type - Single Cell WGA Kit, Complete WGA Kit, WGA Reamplification Kit, WGA & Chip DNA Kit and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Asia-Pacific Historic Review for Whole Genome Amplification (WGA) by Type - Single Cell WGA Kit, Complete WGA Kit, WGA Reamplification Kit, WGA & Chip DNA Kit and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 163: Asia-Pacific 16-Year Perspective for Whole Genome Amplification (WGA) by Type - Percentage Breakdown of Value Sales for Single Cell WGA Kit, Complete WGA Kit, WGA Reamplification Kit, WGA & Chip DNA Kit and Other Types for the Years 2014, 2025 & 2030
  • TABLE 164: Asia-Pacific Recent Past, Current & Future Analysis for Whole Genome Amplification (WGA) by Application - Other Applications, Drug Discovery & Development Application, Diagnostics Application, Research Application and Forensics Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 165: Asia-Pacific Historic Review for Whole Genome Amplification (WGA) by Application - Other Applications, Drug Discovery & Development Application, Diagnostics Application, Research Application and Forensics Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 166: Asia-Pacific 16-Year Perspective for Whole Genome Amplification (WGA) by Application - Percentage Breakdown of Value Sales for Other Applications, Drug Discovery & Development Application, Diagnostics Application, Research Application and Forensics Application for the Years 2014, 2025 & 2030
  • TABLE 167: Asia-Pacific Recent Past, Current & Future Analysis for Whole Genome Amplification (WGA) by End-user - Pharma & Biotech Companies End-User, Hospitals & Clinics End-User, Research Institutes End-User and Other End-Users - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 168: Asia-Pacific Historic Review for Whole Genome Amplification (WGA) by End-user - Pharma & Biotech Companies End-User, Hospitals & Clinics End-User, Research Institutes End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 169: Asia-Pacific 16-Year Perspective for Whole Genome Amplification (WGA) by End-user - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-User, Hospitals & Clinics End-User, Research Institutes End-User and Other End-Users for the Years 2014, 2025 & 2030
• AUSTRALIA
  • Whole Genome Amplification (WGA) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 170: Australia Recent Past, Current & Future Analysis for Whole Genome Amplification (WGA) by Type - Single Cell WGA Kit, Complete WGA Kit, WGA Reamplification Kit, WGA & Chip DNA Kit and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 171: Australia Historic Review for Whole Genome Amplification (WGA) by Type - Single Cell WGA Kit, Complete WGA Kit, WGA Reamplification Kit, WGA & Chip DNA Kit and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 172: Australia 16-Year Perspective for Whole Genome Amplification (WGA) by Type - Percentage Breakdown of Value Sales for Single Cell WGA Kit, Complete WGA Kit, WGA Reamplification Kit, WGA & Chip DNA Kit and Other Types for the Years 2014, 2025 & 2030
  • TABLE 173: Australia Recent Past, Current & Future Analysis for Whole Genome Amplification (WGA) by Application - Other Applications, Drug Discovery & Development Application, Diagnostics Application, Research Application and Forensics Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 174: Australia Historic Review for Whole Genome Amplification (WGA) by Application - Other Applications, Drug Discovery & Development Application, Diagnostics Application, Research Application and Forensics Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 175: Australia 16-Year Perspective for Whole Genome Amplification (WGA) by Application - Percentage Breakdown of Value Sales for Other Applications, Drug Discovery & Development Application, Diagnostics Application, Research Application and Forensics Application for the Years 2014, 2025 & 2030
  • TABLE 176: Australia Recent Past, Current & Future Analysis for Whole Genome Amplification (WGA) by End-user - Pharma & Biotech Companies End-User, Hospitals & Clinics End-User, Research Institutes End-User and Other End-Users - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 177: Australia Historic Review for Whole Genome Amplification (WGA) by End-user - Pharma & Biotech Companies End-User, Hospitals & Clinics End-User, Research Institutes End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 178: Australia 16-Year Perspective for Whole Genome Amplification (WGA) by End-user - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-User, Hospitals & Clinics End-User, Research Institutes End-User and Other End-Users for the Years 2014, 2025 & 2030
• INDIA
  • Whole Genome Amplification (WGA) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 179: India Recent Past, Current & Future Analysis for Whole Genome Amplification (WGA) by Type - Single Cell WGA Kit, Complete WGA Kit, WGA Reamplification Kit, WGA & Chip DNA Kit and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 180: India Historic Review for Whole Genome Amplification (WGA) by Type - Single Cell WGA Kit, Complete WGA Kit, WGA Reamplification Kit, WGA & Chip DNA Kit and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 181: India 16-Year Perspective for Whole Genome Amplification (WGA) by Type - Percentage Breakdown of Value Sales for Single Cell WGA Kit, Complete WGA Kit, WGA Reamplification Kit, WGA & Chip DNA Kit and Other Types for the Years 2014, 2025 & 2030
  • TABLE 182: India Recent Past, Current & Future Analysis for Whole Genome Amplification (WGA) by Application - Other Applications, Drug Discovery & Development Application, Diagnostics Application, Research Application and Forensics Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 183: India Historic Review for Whole Genome Amplification (WGA) by Application - Other Applications, Drug Discovery & Development Application, Diagnostics Application, Research Application and Forensics Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 184: India 16-Year Perspective for Whole Genome Amplification (WGA) by Application - Percentage Breakdown of Value Sales for Other Applications, Drug Discovery & Development Application, Diagnostics Application, Research Application and Forensics Application for the Years 2014, 2025 & 2030
  • TABLE 185: India Recent Past, Current & Future Analysis for Whole Genome Amplification (WGA) by End-user - Pharma & Biotech Companies End-User, Hospitals & Clinics End-User, Research Institutes End-User and Other End-Users - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 186: India Historic Review for Whole Genome Amplification (WGA) by End-user - Pharma & Biotech Companies End-User, Hospitals & Clinics End-User, Research Institutes End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 187: India 16-Year Perspective for Whole Genome Amplification (WGA) by End-user - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-User, Hospitals & Clinics End-User, Research Institutes End-User and Other End-Users for the Years 2014, 2025 & 2030
• SOUTH KOREA
  • TABLE 188: South Korea Recent Past, Current & Future Analysis for Whole Genome Amplification (WGA) by Type - Single Cell WGA Kit, Complete WGA Kit, WGA Reamplification Kit, WGA & Chip DNA Kit and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 189: South Korea Historic Review for Whole Genome Amplification (WGA) by Type - Single Cell WGA Kit, Complete WGA Kit, WGA Reamplification Kit, WGA & Chip DNA Kit and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 190: South Korea 16-Year Perspective for Whole Genome Amplification (WGA) by Type - Percentage Breakdown of Value Sales for Single Cell WGA Kit, Complete WGA Kit, WGA Reamplification Kit, WGA & Chip DNA Kit and Other Types for the Years 2014, 2025 & 2030
  • TABLE 191: South Korea Recent Past, Current & Future Analysis for Whole Genome Amplification (WGA) by Application - Other Applications, Drug Discovery & Development Application, Diagnostics Application, Research Application and Forensics Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 192: South Korea Historic Review for Whole Genome Amplification (WGA) by Application - Other Applications, Drug Discovery & Development Application, Diagnostics Application, Research Application and Forensics Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 193: South Korea 16-Year Perspective for Whole Genome Amplification (WGA) by Application - Percentage Breakdown of Value Sales for Other Applications, Drug Discovery & Development Application, Diagnostics Application, Research Application and Forensics Application for the Years 2014, 2025 & 2030
  • TABLE 194: South Korea Recent Past, Current & Future Analysis for Whole Genome Amplification (WGA) by End-user - Pharma & Biotech Companies End-User, Hospitals & Clinics End-User, Research Institutes End-User and Other End-Users - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 195: South Korea Historic Review for Whole Genome Amplification (WGA) by End-user - Pharma & Biotech Companies End-User, Hospitals & Clinics End-User, Research Institutes End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 196: South Korea 16-Year Perspective for Whole Genome Amplification (WGA) by End-user - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-User, Hospitals & Clinics End-User, Research Institutes End-User and Other End-Users for the Years 2014, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 197: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Whole Genome Amplification (WGA) by Type - Single Cell WGA Kit, Complete WGA Kit, WGA Reamplification Kit, WGA & Chip DNA Kit and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Rest of Asia-Pacific Historic Review for Whole Genome Amplification (WGA) by Type - Single Cell WGA Kit, Complete WGA Kit, WGA Reamplification Kit, WGA & Chip DNA Kit and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 199: Rest of Asia-Pacific 16-Year Perspective for Whole Genome Amplification (WGA) by Type - Percentage Breakdown of Value Sales for Single Cell WGA Kit, Complete WGA Kit, WGA Reamplification Kit, WGA & Chip DNA Kit and Other Types for the Years 2014, 2025 & 2030
  • TABLE 200: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Whole Genome Amplification (WGA) by Application - Other Applications, Drug Discovery & Development Application, Diagnostics Application, Research Application and Forensics Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Rest of Asia-Pacific Historic Review for Whole Genome Amplification (WGA) by Application - Other Applications, Drug Discovery & Development Application, Diagnostics Application, Research Application and Forensics Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 202: Rest of Asia-Pacific 16-Year Perspective for Whole Genome Amplification (WGA) by Application - Percentage Breakdown of Value Sales for Other Applications, Drug Discovery & Development Application, Diagnostics Application, Research Application and Forensics Application for the Years 2014, 2025 & 2030
  • TABLE 203: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Whole Genome Amplification (WGA) by End-user - Pharma & Biotech Companies End-User, Hospitals & Clinics End-User, Research Institutes End-User and Other End-Users - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Rest of Asia-Pacific Historic Review for Whole Genome Amplification (WGA) by End-user - Pharma & Biotech Companies End-User, Hospitals & Clinics End-User, Research Institutes End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 205: Rest of Asia-Pacific 16-Year Perspective for Whole Genome Amplification (WGA) by End-user - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-User, Hospitals & Clinics End-User, Research Institutes End-User and Other End-Users for the Years 2014, 2025 & 2030
• LATIN AMERICA
  • Whole Genome Amplification (WGA) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 206: Latin America Recent Past, Current & Future Analysis for Whole Genome Amplification (WGA) by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 207: Latin America Historic Review for Whole Genome Amplification (WGA) by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 208: Latin America 16-Year Perspective for Whole Genome Amplification (WGA) by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
  • TABLE 209: Latin America Recent Past, Current & Future Analysis for Whole Genome Amplification (WGA) by Type - Single Cell WGA Kit, Complete WGA Kit, WGA Reamplification Kit, WGA & Chip DNA Kit and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Latin America Historic Review for Whole Genome Amplification (WGA) by Type - Single Cell WGA Kit, Complete WGA Kit, WGA Reamplification Kit, WGA & Chip DNA Kit and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 211: Latin America 16-Year Perspective for Whole Genome Amplification (WGA) by Type - Percentage Breakdown of Value Sales for Single Cell WGA Kit, Complete WGA Kit, WGA Reamplification Kit, WGA & Chip DNA Kit and Other Types for the Years 2014, 2025 & 2030
  • TABLE 212: Latin America Recent Past, Current & Future Analysis for Whole Genome Amplification (WGA) by Application - Other Applications, Drug Discovery & Development Application, Diagnostics Application, Research Application and Forensics Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Latin America Historic Review for Whole Genome Amplification (WGA) by Application - Other Applications, Drug Discovery & Development Application, Diagnostics Application, Research Application and Forensics Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 214: Latin America 16-Year Perspective for Whole Genome Amplification (WGA) by Application - Percentage Breakdown of Value Sales for Other Applications, Drug Discovery & Development Application, Diagnostics Application, Research Application and Forensics Application for the Years 2014, 2025 & 2030
  • TABLE 215: Latin America Recent Past, Current & Future Analysis for Whole Genome Amplification (WGA) by End-user - Pharma & Biotech Companies End-User, Hospitals & Clinics End-User, Research Institutes End-User and Other End-Users - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Latin America Historic Review for Whole Genome Amplification (WGA) by End-user - Pharma & Biotech Companies End-User, Hospitals & Clinics End-User, Research Institutes End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 217: Latin America 16-Year Perspective for Whole Genome Amplification (WGA) by End-user - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-User, Hospitals & Clinics End-User, Research Institutes End-User and Other End-Users for the Years 2014, 2025 & 2030
• ARGENTINA
  • TABLE 218: Argentina Recent Past, Current & Future Analysis for Whole Genome Amplification (WGA) by Type - Single Cell WGA Kit, Complete WGA Kit, WGA Reamplification Kit, WGA & Chip DNA Kit and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Argentina Historic Review for Whole Genome Amplification (WGA) by Type - Single Cell WGA Kit, Complete WGA Kit, WGA Reamplification Kit, WGA & Chip DNA Kit and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 220: Argentina 16-Year Perspective for Whole Genome Amplification (WGA) by Type - Percentage Breakdown of Value Sales for Single Cell WGA Kit, Complete WGA Kit, WGA Reamplification Kit, WGA & Chip DNA Kit and Other Types for the Years 2014, 2025 & 2030
  • TABLE 221: Argentina Recent Past, Current & Future Analysis for Whole Genome Amplification (WGA) by Application - Other Applications, Drug Discovery & Development Application, Diagnostics Application, Research Application and Forensics Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Argentina Historic Review for Whole Genome Amplification (WGA) by Application - Other Applications, Drug Discovery & Development Application, Diagnostics Application, Research Application and Forensics Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 223: Argentina 16-Year Perspective for Whole Genome Amplification (WGA) by Application - Percentage Breakdown of Value Sales for Other Applications, Drug Discovery & Development Application, Diagnostics Application, Research Application and Forensics Application for the Years 2014, 2025 & 2030
  • TABLE 224: Argentina Recent Past, Current & Future Analysis for Whole Genome Amplification (WGA) by End-user - Pharma & Biotech Companies End-User, Hospitals & Clinics End-User, Research Institutes End-User and Other End-Users - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 225: Argentina Historic Review for Whole Genome Amplification (WGA) by End-user - Pharma & Biotech Companies End-User, Hospitals & Clinics End-User, Research Institutes End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 226: Argentina 16-Year Perspective for Whole Genome Amplification (WGA) by End-user - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-User, Hospitals & Clinics End-User, Research Institutes End-User and Other End-Users for the Years 2014, 2025 & 2030
• BRAZIL
  • TABLE 227: Brazil Recent Past, Current & Future Analysis for Whole Genome Amplification (WGA) by Type - Single Cell WGA Kit, Complete WGA Kit, WGA Reamplification Kit, WGA & Chip DNA Kit and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 228: Brazil Historic Review for Whole Genome Amplification (WGA) by Type - Single Cell WGA Kit, Complete WGA Kit, WGA Reamplification Kit, WGA & Chip DNA Kit and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 229: Brazil 16-Year Perspective for Whole Genome Amplification (WGA) by Type - Percentage Breakdown of Value Sales for Single Cell WGA Kit, Complete WGA Kit, WGA Reamplification Kit, WGA & Chip DNA Kit and Other Types for the Years 2014, 2025 & 2030
  • TABLE 230: Brazil Recent Past, Current & Future Analysis for Whole Genome Amplification (WGA) by Application - Other Applications, Drug Discovery & Development Application, Diagnostics Application, Research Application and Forensics Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 231: Brazil Historic Review for Whole Genome Amplification (WGA) by Application - Other Applications, Drug Discovery & Development Application, Diagnostics Application, Research Application and Forensics Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 232: Brazil 16-Year Perspective for Whole Genome Amplification (WGA) by Application - Percentage Breakdown of Value Sales for Other Applications, Drug Discovery & Development Application, Diagnostics Application, Research Application and Forensics Application for the Years 2014, 2025 & 2030
  • TABLE 233: Brazil Recent Past, Current & Future Analysis for Whole Genome Amplification (WGA) by End-user - Pharma & Biotech Companies End-User, Hospitals & Clinics End-User, Research Institutes End-User and Other End-Users - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 234: Brazil Historic Review for Whole Genome Amplification (WGA) by End-user - Pharma & Biotech Companies End-User, Hospitals & Clinics End-User, Research Institutes End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 235: Brazil 16-Year Perspective for Whole Genome Amplification (WGA) by End-user - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-User, Hospitals & Clinics End-User, Research Institutes End-User and Other End-Users for the Years 2014, 2025 & 2030
• MEXICO
  • TABLE 236: Mexico Recent Past, Current & Future Analysis for Whole Genome Amplification (WGA) by Type - Single Cell WGA Kit, Complete WGA Kit, WGA Reamplification Kit, WGA & Chip DNA Kit and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 237: Mexico Historic Review for Whole Genome Amplification (WGA) by Type - Single Cell WGA Kit, Complete WGA Kit, WGA Reamplification Kit, WGA & Chip DNA Kit and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 238: Mexico 16-Year Perspective for Whole Genome Amplification (WGA) by Type - Percentage Breakdown of Value Sales for Single Cell WGA Kit, Complete WGA Kit, WGA Reamplification Kit, WGA & Chip DNA Kit and Other Types for the Years 2014, 2025 & 2030
  • TABLE 239: Mexico Recent Past, Current & Future Analysis for Whole Genome Amplification (WGA) by Application - Other Applications, Drug Discovery & Development Application, Diagnostics Application, Research Application and Forensics Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 240: Mexico Historic Review for Whole Genome Amplification (WGA) by Application - Other Applications, Drug Discovery & Development Application, Diagnostics Application, Research Application and Forensics Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 241: Mexico 16-Year Perspective for Whole Genome Amplification (WGA) by Application - Percentage Breakdown of Value Sales for Other Applications, Drug Discovery & Development Application, Diagnostics Application, Research Application and Forensics Application for the Years 2014, 2025 & 2030
  • TABLE 242: Mexico Recent Past, Current & Future Analysis for Whole Genome Amplification (WGA) by End-user - Pharma & Biotech Companies End-User, Hospitals & Clinics End-User, Research Institutes End-User and Other End-Users - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 243: Mexico Historic Review for Whole Genome Amplification (WGA) by End-user - Pharma & Biotech Companies End-User, Hospitals & Clinics End-User, Research Institutes End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 244: Mexico 16-Year Perspective for Whole Genome Amplification (WGA) by End-user - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-User, Hospitals & Clinics End-User, Research Institutes End-User and Other End-Users for the Years 2014, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 245: Rest of Latin America Recent Past, Current & Future Analysis for Whole Genome Amplification (WGA) by Type - Single Cell WGA Kit, Complete WGA Kit, WGA Reamplification Kit, WGA & Chip DNA Kit and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 246: Rest of Latin America Historic Review for Whole Genome Amplification (WGA) by Type - Single Cell WGA Kit, Complete WGA Kit, WGA Reamplification Kit, WGA & Chip DNA Kit and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 247: Rest of Latin America 16-Year Perspective for Whole Genome Amplification (WGA) by Type - Percentage Breakdown of Value Sales for Single Cell WGA Kit, Complete WGA Kit, WGA Reamplification Kit, WGA & Chip DNA Kit and Other Types for the Years 2014, 2025 & 2030
  • TABLE 248: Rest of Latin America Recent Past, Current & Future Analysis for Whole Genome Amplification (WGA) by Application - Other Applications, Drug Discovery & Development Application, Diagnostics Application, Research Application and Forensics Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 249: Rest of Latin America Historic Review for Whole Genome Amplification (WGA) by Application - Other Applications, Drug Discovery & Development Application, Diagnostics Application, Research Application and Forensics Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 250: Rest of Latin America 16-Year Perspective for Whole Genome Amplification (WGA) by Application - Percentage Breakdown of Value Sales for Other Applications, Drug Discovery & Development Application, Diagnostics Application, Research Application and Forensics Application for the Years 2014, 2025 & 2030
  • TABLE 251: Rest of Latin America Recent Past, Current & Future Analysis for Whole Genome Amplification (WGA) by End-user - Pharma & Biotech Companies End-User, Hospitals & Clinics End-User, Research Institutes End-User and Other End-Users - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 252: Rest of Latin America Historic Review for Whole Genome Amplification (WGA) by End-user - Pharma & Biotech Companies End-User, Hospitals & Clinics End-User, Research Institutes End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 253: Rest of Latin America 16-Year Perspective for Whole Genome Amplification (WGA) by End-user - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-User, Hospitals & Clinics End-User, Research Institutes End-User and Other End-Users for the Years 2014, 2025 & 2030
• MIDDLE EAST
  • Whole Genome Amplification (WGA) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 254: Middle East Recent Past, Current & Future Analysis for Whole Genome Amplification (WGA) by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 255: Middle East Historic Review for Whole Genome Amplification (WGA) by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 256: Middle East 16-Year Perspective for Whole Genome Amplification (WGA) by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
  • TABLE 257: Middle East Recent Past, Current & Future Analysis for Whole Genome Amplification (WGA) by Type - Single Cell WGA Kit, Complete WGA Kit, WGA Reamplification Kit, WGA & Chip DNA Kit and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Middle East Historic Review for Whole Genome Amplification (WGA) by Type - Single Cell WGA Kit, Complete WGA Kit, WGA Reamplification Kit, WGA & Chip DNA Kit and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 259: Middle East 16-Year Perspective for Whole Genome Amplification (WGA) by Type - Percentage Breakdown of Value Sales for Single Cell WGA Kit, Complete WGA Kit, WGA Reamplification Kit, WGA & Chip DNA Kit and Other Types for the Years 2014, 2025 & 2030
  • TABLE 260: Middle East Recent Past, Current & Future Analysis for Whole Genome Amplification (WGA) by Application - Other Applications, Drug Discovery & Development Application, Diagnostics Application, Research Application and Forensics Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Middle East Historic Review for Whole Genome Amplification (WGA) by Application - Other Applications, Drug Discovery & Development Application, Diagnostics Application, Research Application and Forensics Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 262: Middle East 16-Year Perspective for Whole Genome Amplification (WGA) by Application - Percentage Breakdown of Value Sales for Other Applications, Drug Discovery & Development Application, Diagnostics Application, Research Application and Forensics Application for the Years 2014, 2025 & 2030
  • TABLE 263: Middle East Recent Past, Current & Future Analysis for Whole Genome Amplification (WGA) by End-user - Pharma & Biotech Companies End-User, Hospitals & Clinics End-User, Research Institutes End-User and Other End-Users - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Middle East Historic Review for Whole Genome Amplification (WGA) by End-user - Pharma & Biotech Companies End-User, Hospitals & Clinics End-User, Research Institutes End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 265: Middle East 16-Year Perspective for Whole Genome Amplification (WGA) by End-user - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-User, Hospitals & Clinics End-User, Research Institutes End-User and Other End-Users for the Years 2014, 2025 & 2030
• IRAN
  • TABLE 266: Iran Recent Past, Current & Future Analysis for Whole Genome Amplification (WGA) by Type - Single Cell WGA Kit, Complete WGA Kit, WGA Reamplification Kit, WGA & Chip DNA Kit and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Iran Historic Review for Whole Genome Amplification (WGA) by Type - Single Cell WGA Kit, Complete WGA Kit, WGA Reamplification Kit, WGA & Chip DNA Kit and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 268: Iran 16-Year Perspective for Whole Genome Amplification (WGA) by Type - Percentage Breakdown of Value Sales for Single Cell WGA Kit, Complete WGA Kit, WGA Reamplification Kit, WGA & Chip DNA Kit and Other Types for the Years 2014, 2025 & 2030
  • TABLE 269: Iran Recent Past, Current & Future Analysis for Whole Genome Amplification (WGA) by Application - Other Applications, Drug Discovery & Development Application, Diagnostics Application, Research Application and Forensics Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Iran Historic Review for Whole Genome Amplification (WGA) by Application - Other Applications, Drug Discovery & Development Application, Diagnostics Application, Research Application and Forensics Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 271: Iran 16-Year Perspective for Whole Genome Amplification (WGA) by Application - Percentage Breakdown of Value Sales for Other Applications, Drug Discovery & Development Application, Diagnostics Application, Research Application and Forensics Application for the Years 2014, 2025 & 2030
  • TABLE 272: Iran Recent Past, Current & Future Analysis for Whole Genome Amplification (WGA) by End-user - Pharma & Biotech Companies End-User, Hospitals & Clinics End-User, Research Institutes End-User and Other End-Users - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Iran Historic Review for Whole Genome Amplification (WGA) by End-user - Pharma & Biotech Companies End-User, Hospitals & Clinics End-User, Research Institutes End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 274: Iran 16-Year Perspective for Whole Genome Amplification (WGA) by End-user - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-User, Hospitals & Clinics End-User, Research Institutes End-User and Other End-Users for the Years 2014, 2025 & 2030
• ISRAEL
  • TABLE 275: Israel Recent Past, Current & Future Analysis for Whole Genome Amplification (WGA) by Type - Single Cell WGA Kit, Complete WGA Kit, WGA Reamplification Kit, WGA & Chip DNA Kit and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Israel Historic Review for Whole Genome Amplification (WGA) by Type - Single Cell WGA Kit, Complete WGA Kit, WGA Reamplification Kit, WGA & Chip DNA Kit and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 277: Israel 16-Year Perspective for Whole Genome Amplification (WGA) by Type - Percentage Breakdown of Value Sales for Single Cell WGA Kit, Complete WGA Kit, WGA Reamplification Kit, WGA & Chip DNA Kit and Other Types for the Years 2014, 2025 & 2030
  • TABLE 278: Israel Recent Past, Current & Future Analysis for Whole Genome Amplification (WGA) by Application - Other Applications, Drug Discovery & Development Application, Diagnostics Application, Research Application and Forensics Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 279: Israel Historic Review for Whole Genome Amplification (WGA) by Application - Other Applications, Drug Discovery & Development Application, Diagnostics Application, Research Application and Forensics Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 280: Israel 16-Year Perspective for Whole Genome Amplification (WGA) by Application - Percentage Breakdown of Value Sales for Other Applications, Drug Discovery & Development Application, Diagnostics Application, Research Application and Forensics Application for the Years 2014, 2025 & 2030
  • TABLE 281: Israel Recent Past, Current & Future Analysis for Whole Genome Amplification (WGA) by End-user - Pharma & Biotech Companies End-User, Hospitals & Clinics End-User, Research Institutes End-User and Other End-Users - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 282: Israel Historic Review for Whole Genome Amplification (WGA) by End-user - Pharma & Biotech Companies End-User, Hospitals & Clinics End-User, Research Institutes End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 283: Israel 16-Year Perspective for Whole Genome Amplification (WGA) by End-user - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-User, Hospitals & Clinics End-User, Research Institutes End-User and Other End-Users for the Years 2014, 2025 & 2030
• SAUDI ARABIA
  • TABLE 284: Saudi Arabia Recent Past, Current & Future Analysis for Whole Genome Amplification (WGA) by Type - Single Cell WGA Kit, Complete WGA Kit, WGA Reamplification Kit, WGA & Chip DNA Kit and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 285: Saudi Arabia Historic Review for Whole Genome Amplification (WGA) by Type - Single Cell WGA Kit, Complete WGA Kit, WGA Reamplification Kit, WGA & Chip DNA Kit and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 286: Saudi Arabia 16-Year Perspective for Whole Genome Amplification (WGA) by Type - Percentage Breakdown of Value Sales for Single Cell WGA Kit, Complete WGA Kit, WGA Reamplification Kit, WGA & Chip DNA Kit and Other Types for the Years 2014, 2025 & 2030
  • TABLE 287: Saudi Arabia Recent Past, Current & Future Analysis for Whole Genome Amplification (WGA) by Application - Other Applications, Drug Discovery & Development Application, Diagnostics Application, Research Application and Forensics Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 288: Saudi Arabia Historic Review for Whole Genome Amplification (WGA) by Application - Other Applications, Drug Discovery & Development Application, Diagnostics Application, Research Application and Forensics Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 289: Saudi Arabia 16-Year Perspective for Whole Genome Amplification (WGA) by Application - Percentage Breakdown of Value Sales for Other Applications, Drug Discovery & Development Application, Diagnostics Application, Research Application and Forensics Application for the Years 2014, 2025 & 2030
  • TABLE 290: Saudi Arabia Recent Past, Current & Future Analysis for Whole Genome Amplification (WGA) by End-user - Pharma & Biotech Companies End-User, Hospitals & Clinics End-User, Research Institutes End-User and Other End-Users - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 291: Saudi Arabia Historic Review for Whole Genome Amplification (WGA) by End-user - Pharma & Biotech Companies End-User, Hospitals & Clinics End-User, Research Institutes End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 292: Saudi Arabia 16-Year Perspective for Whole Genome Amplification (WGA) by End-user - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-User, Hospitals & Clinics End-User, Research Institutes End-User and Other End-Users for the Years 2014, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 293: UAE Recent Past, Current & Future Analysis for Whole Genome Amplification (WGA) by Type - Single Cell WGA Kit, Complete WGA Kit, WGA Reamplification Kit, WGA & Chip DNA Kit and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 294: UAE Historic Review for Whole Genome Amplification (WGA) by Type - Single Cell WGA Kit, Complete WGA Kit, WGA Reamplification Kit, WGA & Chip DNA Kit and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 295: UAE 16-Year Perspective for Whole Genome Amplification (WGA) by Type - Percentage Breakdown of Value Sales for Single Cell WGA Kit, Complete WGA Kit, WGA Reamplification Kit, WGA & Chip DNA Kit and Other Types for the Years 2014, 2025 & 2030
  • TABLE 296: UAE Recent Past, Current & Future Analysis for Whole Genome Amplification (WGA) by Application - Other Applications, Drug Discovery & Development Application, Diagnostics Application, Research Application and Forensics Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 297: UAE Historic Review for Whole Genome Amplification (WGA) by Application - Other Applications, Drug Discovery & Development Application, Diagnostics Application, Research Application and Forensics Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 298: UAE 16-Year Perspective for Whole Genome Amplification (WGA) by Application - Percentage Breakdown of Value Sales for Other Applications, Drug Discovery & Development Application, Diagnostics Application, Research Application and Forensics Application for the Years 2014, 2025 & 2030
  • TABLE 299: UAE Recent Past, Current & Future Analysis for Whole Genome Amplification (WGA) by End-user - Pharma & Biotech Companies End-User, Hospitals & Clinics End-User, Research Institutes End-User and Other End-Users - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 300: UAE Historic Review for Whole Genome Amplification (WGA) by End-user - Pharma & Biotech Companies End-User, Hospitals & Clinics End-User, Research Institutes End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 301: UAE 16-Year Perspective for Whole Genome Amplification (WGA) by End-user - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-User, Hospitals & Clinics End-User, Research Institutes End-User and Other End-Users for the Years 2014, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 302: Rest of Middle East Recent Past, Current & Future Analysis for Whole Genome Amplification (WGA) by Type - Single Cell WGA Kit, Complete WGA Kit, WGA Reamplification Kit, WGA & Chip DNA Kit and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 303: Rest of Middle East Historic Review for Whole Genome Amplification (WGA) by Type - Single Cell WGA Kit, Complete WGA Kit, WGA Reamplification Kit, WGA & Chip DNA Kit and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 304: Rest of Middle East 16-Year Perspective for Whole Genome Amplification (WGA) by Type - Percentage Breakdown of Value Sales for Single Cell WGA Kit, Complete WGA Kit, WGA Reamplification Kit, WGA & Chip DNA Kit and Other Types for the Years 2014, 2025 & 2030
  • TABLE 305: Rest of Middle East Recent Past, Current & Future Analysis for Whole Genome Amplification (WGA) by Application - Other Applications, Drug Discovery & Development Application, Diagnostics Application, Research Application and Forensics Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 306: Rest of Middle East Historic Review for Whole Genome Amplification (WGA) by Application - Other Applications, Drug Discovery & Development Application, Diagnostics Application, Research Application and Forensics Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 307: Rest of Middle East 16-Year Perspective for Whole Genome Amplification (WGA) by Application - Percentage Breakdown of Value Sales for Other Applications, Drug Discovery & Development Application, Diagnostics Application, Research Application and Forensics Application for the Years 2014, 2025 & 2030
  • TABLE 308: Rest of Middle East Recent Past, Current & Future Analysis for Whole Genome Amplification (WGA) by End-user - Pharma & Biotech Companies End-User, Hospitals & Clinics End-User, Research Institutes End-User and Other End-Users - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 309: Rest of Middle East Historic Review for Whole Genome Amplification (WGA) by End-user - Pharma & Biotech Companies End-User, Hospitals & Clinics End-User, Research Institutes End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 310: Rest of Middle East 16-Year Perspective for Whole Genome Amplification (WGA) by End-user - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-User, Hospitals & Clinics End-User, Research Institutes End-User and Other End-Users for the Years 2014, 2025 & 2030
• AFRICA
  • Whole Genome Amplification (WGA) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 311: Africa Recent Past, Current & Future Analysis for Whole Genome Amplification (WGA) by Type - Single Cell WGA Kit, Complete WGA Kit, WGA Reamplification Kit, WGA & Chip DNA Kit and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 312: Africa Historic Review for Whole Genome Amplification (WGA) by Type - Single Cell WGA Kit, Complete WGA Kit, WGA Reamplification Kit, WGA & Chip DNA Kit and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 313: Africa 16-Year Perspective for Whole Genome Amplification (WGA) by Type - Percentage Breakdown of Value Sales for Single Cell WGA Kit, Complete WGA Kit, WGA Reamplification Kit, WGA & Chip DNA Kit and Other Types for the Years 2014, 2025 & 2030
  • TABLE 314: Africa Recent Past, Current & Future Analysis for Whole Genome Amplification (WGA) by Application - Other Applications, Drug Discovery & Development Application, Diagnostics Application, Research Application and Forensics Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 315: Africa Historic Review for Whole Genome Amplification (WGA) by Application - Other Applications, Drug Discovery & Development Application, Diagnostics Application, Research Application and Forensics Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 316: Africa 16-Year Perspective for Whole Genome Amplification (WGA) by Application - Percentage Breakdown of Value Sales for Other Applications, Drug Discovery & Development Application, Diagnostics Application, Research Application and Forensics Application for the Years 2014, 2025 & 2030
  • TABLE 317: Africa Recent Past, Current & Future Analysis for Whole Genome Amplification (WGA) by End-user - Pharma & Biotech Companies End-User, Hospitals & Clinics End-User, Research Institutes End-User and Other End-Users - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 318: Africa Historic Review for Whole Genome Amplification (WGA) by End-user - Pharma & Biotech Companies End-User, Hospitals & Clinics End-User, Research Institutes End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 319: Africa 16-Year Perspective for Whole Genome Amplification (WGA) by End-user - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-User, Hospitals & Clinics End-User, Research Institutes End-User and Other End-Users for the Years 2014, 2025 & 2030

IV. COMPETITION